Sponsor

Institut Catala D'oncologia

Spain Avinguda De La Gran Via De L'hospitalet 199-203, 08908 L'hospitalet De Llobregat, Spain

About the sponsor

The clinical research activity centers on breast cancer prevention in women with a BRCA1 germline mutation, with a focus on reducing the risk of invasive breast cancer and ductal carcinoma in situ.

BRCA1-associated cancer risk
Primary prevention of breast cancer
Non-malignant and pre-invasive breast lesions

This area reflects a strong interest in genetic susceptibility and cancer prevention strategies for women at elevated inherited risk.

About Specializations

Institut Catala D'oncologia runs clinical trials in conditions such as Breast cancer, Prophylaxis, BRCA1 gene mutation, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Breast cancer+2

Not recruiting

Registered drug

Study on Denosumab to Prevent Breast Cancer in Women with BRCA1 Mutation

Registered drug

Austria

Participants:18–64 years · Healthy volunteers
Substances:Denosumab
Sponsor:ANZ Breast Cancer Trials Group Limited

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →